Tyvaso DPI™ (inhaled treprostinil)

DRUG/DEVICE
Treprostinil inhalation powder
ROUTE OF ADMINISTRATION
Inhaled
THERAPEUTIC PLATFORM
Tyvaso®
CLINICAL TRIAL
TERRITORY
Worldwide
COMMERCIAL PRODUCT
STATUS
Our New Drug Application for Tyvaso DPI is currently pending FDA review.
Tyvaso DPI is an investigational combination product that is not approved for any use in any country, and the Tyvaso DPI tradename is pending FDA review.